Literature DB >> 22006508

Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.

Ondrej Stanek1, Irena Linhartova, Laleh Majlessi, Claude Leclerc, Peter Sebo.   

Abstract

The choice of tools that enable efficient targeting of exogenous antigens (Ag) for processing and presentation by professional Ag-presenting cells (APC) remains limited. This represents, indeed, a bottleneck in development of vaccines inducing specific T-cell responses. Here, we describe a novel strategy of Ag delivery into APCs. The Ag of choice is fused to the N- or C-terminus of streptavidin (SA) and tetrameric Ag-SA or SA-Ag fusion proteins are produced in E. coli and purified by 2-Iminobiotin-Agarose affinity chromatography. Alternatively, Ag-SA proteins are purified from urea extracts of E. coli inclusion bodies and refolded in vitro into functional tetramers. Complexes with biotinylated antibodies targeting cell surface receptors are formed and used to deliver the Ags of choice for processing and presentation by APCs and induction of Ag-specific CD4+ and CD8+ T-cell responses in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22006508     DOI: 10.1007/s12033-011-9459-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  46 in total

1.  Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

Authors:  L A van Pinxteren; P Ravn; E M Agger; J Pollock; P Andersen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

Authors:  J Karttunen; S Sanderson; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

4.  Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein.

Authors:  Welson Wen-Shang Wang; Dipankar Das; Stephen A McQuarrie; Mavanur R Suresh
Journal:  Eur J Pharm Biopharm       Date:  2006-12-27       Impact factor: 5.571

Review 5.  The perfect mix: recent progress in adjuvant research.

Authors:  Bruno Guy
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

6.  A versatile bifunctional dendritic cell targeting vaccine vector.

Authors:  Welson W Wang; Dipankar Das; Mavanur R Suresh
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

7.  Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma.

Authors:  Naotaka Shibagaki; Mark C Udey
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

8.  Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis.

Authors:  Maika Durantez; Catherine Fayolle; Noelia Casares; Virginia Belsue; José I Riezu-Boj; Pablo Sarobe; Jesús Prieto; Francisco Borrás-Cuesta; Claude Leclerc; Juan J Lasarte
Journal:  Vaccine       Date:  2010-09-15       Impact factor: 3.641

9.  Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.

Authors:  Girishchandra B Patel; Hongyan Zhou; Amalia Ponce; Wangxue Chen
Journal:  Vaccine       Date:  2007-10-05       Impact factor: 3.641

Review 10.  New tools for antigen delivery to the MHC class I pathway.

Authors:  Gabriel Morón; Gilles Dadaglio; Claude Leclerc
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

View more
  3 in total

1.  A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies.

Authors:  Cindy Bernelin-Cottet; Charlotte Deloizy; Ondrej Stanek; Céline Barc; Edwige Bouguyon; Céline Urien; Olivier Boulesteix; Jérémy Pezant; Charles-Adrien Richard; Mohammed Moudjou; Bruno Da Costa; Luc Jouneau; Christophe Chevalier; Claude Leclerc; Peter Sebo; Nicolas Bertho; Isabelle Schwartz-Cornil
Journal:  Front Immunol       Date:  2016-12-26       Impact factor: 7.561

2.  Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines.

Authors:  Jitka Mucksová; Jiří Plachý; Ondřej Staněk; Jiří Hejnar; Jiří Kalina; Barbora Benešová; Pavel Trefil
Journal:  Vet Res       Date:  2017-04-05       Impact factor: 3.683

3.  A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

Authors:  François Anna; Jodie Lopez; Fanny Moncoq; Catherine Blanc; Pierre Authié; Amandine Noirat; Ingrid Fert; Philippe Souque; Fabien Nevo; Alexandre Pawlik; David Hardy; Sophie Goyard; Denis Hudrisier; Roland Brosch; Françoise Guinet; Olivier Neyrolles; Pierre Charneau; Laleh Majlessi
Journal:  Mucosal Immunol       Date:  2022-09-14       Impact factor: 8.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.